Heft Nr. 1/2026
Anzeigenschluss: 23.01.2026
Erscheinungstermin: 06.02.2026
Top-Thema
Neue Strategien bei Tumoren von Magen und Speiseröhre
Schwerpunkt
Aktuelles zur Diagnostik und Therapie des Prostatakarzinoms
Medizin
Akute myeloische Leukämie
Montesinos P et al.
Quizartinib for Newly Diagnosed FLT3-ITD–Negative Acute Myeloid Leukemia: The Randomized, Double-Blind, Placebo-Controlled, Phase 2 QUIWI Study
Myelom
Baertsch MA et al.
Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial
Kopf-Hals-Tumoren
Sangal NR et al.
Immunotherapy Utilization Outcomes in Distantly Metastatic Head and Neck Squamous Cell Carcinoma
Orale Präkanzerosen
Palatnik B et al.
Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy
Darmkrebs
Robbins EC et al.
Colorectal cancer incidence after the first surveillance colonoscopy and the need for ongoing surveillance: a retrospective, cohort analysis
NSCLC
Spigel DR et al.
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial
Brustkrebs
Kunkler IH et al.
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer
Brustkrebs
Tolaney M et al.
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
Prostatakarzinom
Sushentsev M et al.
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial
Melanom
Kähler KC et al.
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma
Allgemeine Onkologie – Tageszeit für OP
Sim JH et al.
Association between surgical start time and postoperative mortality, morbidity and healthcare utilisation in elective non-cardiac surgeries: a retrospective, single-centre study using propensity score matching
Allgemeine Onkologie – Rezidivangst
Lyhne JD et al.
E-Health Intervention for Fear of Cancer Recurrence: A Randomized Clinical Trial
Kongressbericht 1: ASH 2025
Highlights vom Kongress der American Society of Hematology vom 06. bis 09.12.2025 in Orlando
Kongressbericht 2: AIO-Herbstkongress 2025
Aktuelles vom 22. AIO-Herbstkongress in Berlin (20. – 22.11.2025)
Kongressbericht 3: SABCS 2025
Aktuelles vom 47th Annual San Antonio Breast Cancer Symposium (09. – 12.12.2025)
*Die Redaktion behält sich aktuelle Änderungen vor.